CEL SCI Corp Stock Math Transform Inverse Tangent Over Price Movement

CVM Stock  USD 3.69  0.12  3.36%   
The math transform module provides an execution environment for Inverse Tangent Over Price Movement transformation and related indicators on CEL SCI. This view tracks price transformations that reveal shifts in trend structure to support structured performance interpretation without implying advice.

Transformation
This analysis covers sixty-one data points across the selected time horizon. CEL SCI Corp Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe CEL SCI price patterns.

CEL SCI Technical Analysis Modules

Most technical analysis of CEL SCI help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CEL from various momentum indicators to cycle indicators. When you analyze CEL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company was incorporated in 1983 and is headquartered in Vienna, Virginia. Cel-Sci Corp operates under Biotechnology classification in the United States and is traded on AMEX Exchange. This overview emphasizes how CEL SCI compares to peers on valuation quality and operating consistency. Current metrics include P/B of 2.71. CEL SCI has a market cap of 30.19 M, ROE of -2.12%.

Methodology

Unless otherwise specified, financial data for CEL SCI Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CEL (USA Stocks:CVM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

CEL SCI Corp has active sell-side coverage. Source-validated coverage currently shows 1 approved analyst, while broader market-consensus totals may differ across providers due to methodology and update timing. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on February 25th, 2026

Become your own money manager

A reliable portfolio-monitoring process is important because investors need to see whether CEL SCI Corp is improving total return without quietly increasing concentration or risk. That means looking at contribution to return, volatility, and correlation rather than relying on price movement alone.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Dividend Beast Idea
Dividend Beast
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 20 shares
ESG Investing Idea
ESG Investing
Invested few shares
Momentum Idea
Momentum
Invested over 40 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 20 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares

More Resources for CEL Stock Analysis

A comprehensive view of CEL SCI Corp starts with financial statements and ratio context. CEL SCI's financial ratios translate raw accounting data into comparable profitability and efficiency signals. Selected reports below provide context for CEL Stock:
CEL SCI has a market cap of 30.19 M, ROE of -2.12%. Trending Equities can help frame allocation decisions. This includes a position in CEL SCI Corp across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
CEL SCI currently shows ROE of -2.12%, market cap of 30.19 Million. This analysis of CEL SCI works best as a complementary layer when evaluating how the security fits in a broader portfolio. For CEL SCI, the analytical tools below add portfolio-level context that single-security review alone cannot provide. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
 Earnings Share
-3.70
 Revenue Per Share
0.001
 Quarterly Revenue Growth
-0.63
 Return On Assets
-0.60
 Return On Equity
-2.12
CEL SCI Corp's market price can diverge from book value, the accounting figure shown on CEL's balance sheet. CEL SCI's market capitalization is 30.19 M. At P/B 2.71, CEL SCI trades moderately above book value. Enterprise value stands at 33.02 M. Value and price for CEL SCI are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
It is useful to distinguish CEL SCI's value from its trading price, which are computed with different methods. For CEL SCI, key inputs include a P/B ratio of 2.71, and ROE of -2.12%. Where CEL SCI trades at any moment depends on the balance of buying and selling pressure.